DocGo Inc. (NASDAQ:DCGO) Receives $2.38 Average Price Target from Brokerages

DocGo Inc. (NASDAQ:DCGO) has received a consensus recommendation of “Hold” from the six research firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $2.3750.

A number of brokerages recently weighed in on DCGO. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Needham & Company LLC restated a “buy” rating and issued a $3.00 price objective on shares of DocGo in a report on Tuesday, March 17th. Stifel Nicolaus decreased their price objective on shares of DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a report on Tuesday, March 17th. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Finally, Canaccord Genuity Group decreased their price objective on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 25th.

Institutional Investors Weigh In On DocGo

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its holdings in DocGo by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after purchasing an additional 73,900 shares during the last quarter. State Street Corp boosted its holdings in DocGo by 2.0% in the fourth quarter. State Street Corp now owns 1,969,603 shares of the company’s stock worth $1,729,000 after purchasing an additional 39,125 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in DocGo by 167.1% in the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after purchasing an additional 944,826 shares during the last quarter. Isthmus Partners LLC boosted its holdings in DocGo by 14.0% in the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after purchasing an additional 124,211 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in DocGo by 205.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock worth $707,000 after purchasing an additional 541,670 shares during the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Stock Up 0.1%

Shares of NASDAQ DCGO opened at $0.66 on Friday. DocGo has a twelve month low of $0.49 and a twelve month high of $1.78. The firm has a market cap of $64.98 million, a P/E ratio of -0.34 and a beta of 1.02. The company has a 50 day moving average of $0.62 and a 200 day moving average of $0.77.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%.The firm had revenue of $75.55 million during the quarter, compared to analysts’ expectations of $72.48 million. As a group, equities analysts expect that DocGo will post -0.12 earnings per share for the current fiscal year.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.